Study to Assess the Safety and Efficacy of OCU410ST for Stargardt Disease

Recruiting

Phase 1

Phase 2

Study to Assess the Safety and Efficacy of OCU410ST for Stargardt DiseaseStudy to Assess the Safety and Efficacy of OCU410ST for Stargardt Disease

Sponsor:

Ocugen

Code:

NCT05956626

Conditions

Stargardt Disease

Eligibility Criteria

Sex: All

Age: 6 - 65

Healthy Volunteers: Not accepted

Interventions

OCU410ST

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Ocugen on 2025-03-25.